About this trial
This study aims to compare awake thoracic epidural anesthesia and general anesthesia in thoracotomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 18 to 75 years old.
Both genders.
American Society of Anesthesiologists (ASA) physical status classification II or III.
Scheduled for thoracotomy.
Disqualifiers
Difficult airway management,
Hemodynamically unstable patients, obesity (body mass index >30).
Absolute contraindication to thoracic epidural anesthesia such as (patient refusal, allergy to local anesthetics, coagulopathy, active neurologic disorders, skin infection at insertion site, uncooperative patients, uncontrolled cough, and unfavorable anatomy for thoracic epidural).
Neurological disorders: risk of seizure, unable to cooperate, intracranial mass or brain edema, extensive pleural adhesions or previous pulmonary resections, hypoxemia (PaO2 <60) or hypercarbia (PaCO2 >50)
Trial design
Parallel
Treatments tested in this trial
Awake thoracic epidural anesthesia
DrugPatients will preoperatively receive awake thoracic epidural anesthesia.
General anesthesia
DrugPatients will receive general anesthesia.
Treatment groups
Trial outcomes
Primary outcomes
Assessment the change in pulmonary function
The change in pulmonary function will be assessed using Forced vital capacity (FVC) will be recorded.
Secondary outcomes
Heart rate
Heart rate will be recorded at baseline, and every 15min till the end of surgery.
Mean arterial pressure
Mean arterial pressure will be recorded at baseline, and every 15min till the end of surgery.
Degree of pain
The patients will be instructed how to report pain by means of the visual analogue scale (VAS), in which 0 = "no pain" and 10 = "worst possible pain". VAS will be assessed at post-anesthesia care unit (PACU), 1, 2, 4, 8, 12,18, 24, 36, 48 hours postoperative.
Total morphine consumption
Rescue analgesia of morphine will be given as 3 mg bolus if the VAS \> 3 to be repeated after 30 min if pain persists until the visual analogue scale (VAS) \< 4.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.